• AXIM® Biotechnologies Files Emergency Use Authorization With the FDA for First-in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies

    8 days ago - By San Diego Biotechnology

    SAN DIEGO, Sept. 16, 2020 - AXIM® Biotechnologies, Inc. (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today it has file......
    Read more ...

     

  • Biocept Provides COVID-19 Testing Update with More than 35,000 Specimens Received

    9 days ago - By San Diego Biotechnology

    Announces distribution of approximately 83,000 specimen collection kits to clients
    SAN DIEGO, Sept. 16, 2020 /PRNewswire/ - Biocept, Inc. , a leading commercial provider of molecular technologies designed to provide physicians with cli......
    Read more ...